Literature DB >> 8800793

Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic.

P B Jahrling1, T W Geisbert, N K Jaax, M A Hanes, T G Ksiazek, C J Peters.   

Abstract

This study describes the pathogenesis of the Ebola-Reston (EBO-R) subtype of Ebola virus for experimentally infected cynomolgus monkeys. The disease course of EBO-R in macaques was very similar to human disease and to experimental diseases in macaques following EBO-Zaire and EBO-Sudan infections. Cynomolgus monkeys infected with EBO-R in this experiment developed anorexia, occasional nasal discharge, and splenomegaly, petechial facial hemorrhages and severe subcutaneous hemorrhages in venipuncture sites, similar to human Ebola fever. Five of the six EBO-R infected monkeys died, 8 to 14 days after inoculation. One survived and developed high titered neutralizing antibodies specific for EBO-R. The five acutely ill monkeys shed infectious virus in various bodily secretions. Further, abundant virus was visualized in alveolar interstitial cells and free in the alveoli suggesting the potential for generating infectious aerosols. Thus, taking precautions against aerosol exposures to filovirus infected primates, including humans, seems prudent. This experiment demonstrated that EBO-R was lethal for macaques and was capable of initiating and sustaining the monkey epizootic. Further investigation of this animal model should facilitate development of effective immunization, treatment, and control strategies for Ebola hemorrhagic fever.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800793     DOI: 10.1007/978-3-7091-7482-1_11

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  32 in total

1.  Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein.

Authors:  Tetsuro Ikegami; Masahiro Niikura; Masayuki Saijo; Mary E Miranda; Alan B Calaor; Marvin Hernandez; Luz P Acosta; Daria L Manalo; Ichiro Kurane; Yasuhiro Yoshikawa; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Assessment of rodents as animal models for Reston ebolavirus.

Authors:  Emmie de Wit; Vincent J Munster; Samia A Metwally; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  Ebola: history, treatment, and lessons from a new emerging pathogen.

Authors:  Kevin S Harrod
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-12       Impact factor: 5.464

4.  Ebola virus disease in mice with transplanted human hematopoietic stem cells.

Authors:  Anja Lüdtke; Lisa Oestereich; Paula Ruibal; Stephanie Wurr; Elisa Pallasch; Sabrina Bockholt; Wing Hang Ip; Toni Rieger; Sergio Gómez-Medina; Carol Stocking; Estefanía Rodríguez; Stephan Günther; César Muñoz-Fontela
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

5.  Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.

Authors:  John C Kash; Elke Mühlberger; Victoria Carter; Melanie Grosch; Olivia Perwitasari; Sean C Proll; Matthew J Thomas; Friedemann Weber; Hans-Dieter Klenk; Michael G Katze
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Reston virus causes severe respiratory disease in young domestic pigs.

Authors:  Elaine Haddock; Greg Saturday; Friederike Feldmann; Patrick W Hanley; Atsushi Okumura; Jamie Lovaglio; Dan Long; Tina Thomas; Dana P Scott; Mikayla Pulliam; Jürgen A Richt; Emmie de Wit; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

7.  The Ebola virus genomic replication promoter is bipartite and follows the rule of six.

Authors:  Michael Weik; Sven Enterlein; Kathrin Schlenz; Elke Mühlberger
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.

Authors:  M C Georges-Courbot; A Sanchez; C Y Lu; S Baize; E Leroy; J Lansout-Soukate; C Tévi-Bénissan; A J Georges; S G Trappier; S R Zaki; R Swanepoel; P A Leman; P E Rollin; C J Peters; S T Nichol; T G Ksiazek
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

9.  Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).

Authors:  Sophie J Smither; Michelle Nelson; Lin Eastaugh; Thomas R Laws; Christopher Taylor; Simon A Smith; Francisco J Salguero; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

10.  Ebola virus-like particles protect from lethal Ebola virus infection.

Authors:  Kelly L Warfield; Catharine M Bosio; Brent C Welcher; Emily M Deal; Mansour Mohamadzadeh; Alan Schmaljohn; M Javad Aman; Sina Bavari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.